ID: ALA255038

Max Phase: Preclinical

Molecular Formula: C17H16Cl2N6

Molecular Weight: 375.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCn1cnc2c(NCc3ccc(Cl)c(Cl)c3)nc(C#N)nc21

Standard InChI:  InChI=1S/C17H16Cl2N6/c1-2-3-6-25-10-22-15-16(23-14(8-20)24-17(15)25)21-9-11-4-5-12(18)13(19)7-11/h4-5,7,10H,2-3,6,9H2,1H3,(H,21,23,24)

Standard InChI Key:  FSQIUURXINGUNK-UHFFFAOYSA-N

Associated Targets(Human)

Cathepsin L 3852 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cathepsin B 3822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cathepsin B-like cysteine protease 88 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Trypanosoma brucei 78846 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasma 6361 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 375.26Molecular Weight (Monoisotopic): 374.0813AlogP: 4.42#Rotatable Bonds: 6
Polar Surface Area: 79.42Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.15CX LogP: 4.78CX LogD: 4.78
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.69Np Likeness Score: -1.51

References

1. Mallari JP, Shelat AA, Obrien T, Caffrey CR, Kosinski A, Connelly M, Harbut M, Greenbaum D, McKerrow JH, Guy RK..  (2008)  Development of potent purine-derived nitrile inhibitors of the trypanosomal protease TbcatB.,  51  (3): [PMID:18173229] [10.1021/jm070760l]
2. Mallari JP, Zhu F, Lemoff A, Kaiser M, Lu M, Brun R, Guy RK..  (2010)  Optimization of purine-nitrile TbcatB inhibitors for use in vivo and evaluation of efficacy in murine models.,  18  (23): [PMID:21051236] [10.1016/j.bmc.2010.09.073]

Source